Terbufibrol

This classification denotes an anti-lipidemic agent with the molecular formula C20H24O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W41Z308IA3, chemically known as 4-(3-(4-(1,1-dimethylethyl)phenoxy)-2-hydroxypropoxy)benzoic acid but generally known as terbufibrol, which bears US NIH Compound Identifier 41907. European Medicines Agency schedules Terbufibrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10912MIG. The term TERBUFIBROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). TERBUFIBROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, TERBUFIBROL remains the US FDA Preferred Term for this commodity. Terbufibrol bears US NLM identifiers UMLS ID C0076111 and NCI Concept Code C91031. SMILES: O(c1ccc(C(C)(C)C)cc1)CC(O)COc1ccc(cc1)C(=O)O.